Resultats de la cerca - Adi Diab

Refinar resultats
  1. 1
    Review: Immune‐Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer

    Review: Immune‐Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer per María E. Suärez-Almazor, Sang T. Kim, Noha Abdel‐Wahab, Adi Diab

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    The Impact of Immune Checkpoint Inhibitor-Related Adverse Events and Their Immunosuppressive Treatment on Patients’ Outcomes

    The Impact of Immune Checkpoint Inhibitor-Related Adverse Events and Their Immunosuppressive Treatment on Patients’ Outcomes per Hamzah Abu‐Sbeih, Tenglong Tang, Faisal S. Ali, Daniel H. Johnson, Wei Qiao, Adi Diab, Yinghong Wang

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma

    Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma per Hamzah Abu‐Sbeih, Faisal S. Ali, Wei Qiao, Yang Lü, Sapna P. Patel, Adi Diab, Yinghong Wang

    Publicat 2019
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Assessment of Image-Guided Intratumoral Delivery of Immunotherapeutics in Patients With Cancer

    Assessment of Image-Guided Intratumoral Delivery of Immunotherapeutics in Patients With Cancer per Rahul A. Sheth, Ravi Murthy, David S. Hong, Sapna P. Patel, Michael J. Overman, Adi Diab, Patrick Hwu, Alda L. Tam

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson

    Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson per Yinghong Wang, Hamzah Abu‐Sbeih, Emily Mao, Noman Ali, Faisal S. Ali, Wei Qiao, Phillip Lum, Gottumukkala S. Raju, Gladis Shuttlesworth, John Stroehlein, Adi Diab

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Immune-Related Thyroiditis with Immune Checkpoint Inhibitors

    Immune-Related Thyroiditis with Immune Checkpoint Inhibitors per Priyanka Iyer, Maria E. Cabanillas, Steven G. Waguespack, Mimi I. Hu, Sonali Thosani, Victor Lavis, Naifa L. Busaidy, Sumit K. Subudhi, Adi Diab, Ramona Dadu

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy

    IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy per Daniel H. Johnson, Anisha B. Patel, Marc Uemura, Van Anh Trinh, Natalie Jackson, Chrystia M. Zobniw, Michael T. Tetzlaff, Patrick Hwu, Jonathan L. Curry, Adi Diab

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series

    Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series per K. Holbrook, Jose Lutzky, Michael A. Davies, Jessica Davis, Isabella C. Glitza, Rodabe N. Amaria, Adi Diab, Sapna P. Patel, Asim Amin, Hussein A. Tawbi

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn’s disease: a case report

    Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn’s disease: a case... per Marc Uemura, Van Anh Trinh, Cara Haymaker, Natalie Jackson, Dae Won Kim, James P. Allison, Padmanee Sharma, Luis M. Vence, Chantale Bernatchez, Patrick Hwu, Adi Diab

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors

    Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors per Noha Abdel‐Wahab, Adi Diab, Robert Yu, P. Andrew Futreal, Lindsey A. Criswell, Jean Tayar, Ramona Dadu, Vickie R. Shannon, Sanjay Shete, María E. Suärez-Almazor

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1

    A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1 per Marc Uemura, Faisal Faˈak, Cara Haymaker, Natalie McQuail, Elizabeth Sirmans, Courtney W. Hudgens, Lydia Barbara, Chantale Bernatchez, Jonathan L. Curry, Patrick Hwu, Michael T. Tetzlaff, Adi Diab

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis

    Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis per Maen Abdelrahim, Omar Mamlouk, Heather Lin, Jamie S. Lin, Valda D. Page, Noha Abdel‐Wahab, Joshua T. Swan, Umut Selamet, Cassian Yee, Adi Diab, Wadi N. Suki, Ala Abudayyeh

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View

    Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View per Maen Abdelrahim, Abdullah Esmail, Ashish Saharia, Ala Abudayyeh, Noha Abdel‐Wahab, Adi Diab, Naoka Murakami, Ahmed O. Kaseb, Jenny C. Chang, A. Osama Gaber, Rafik M. Ghobrial

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  14. 14
    Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study

    Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study per Meredith Pelster, Stephen K. Gruschkus, Roland L. Bassett, Dan S. Gombos, Michael Shephard, Liberty Posada, Maura S. Glover, Rinata Simien, Adi Diab, Patrick Hwu, Brett W. Carter, Sapna P. Patel

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Current strategies for intratumoural immunotherapy – Beyond immune checkpoint inhibition

    Current strategies for intratumoural immunotherapy – Beyond immune checkpoint inhibition per Jianda Yuan, Anuradha Khilnani, Joshua Brody, Robert H.I. Andtbacka, Siwen Hu‐Lieskovan, Jason J. Luke, Adi Diab, Aurélien Marabelle, Alexandra Snyder, Z. Alexander Cao, F. Stephen Hodi

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  16. 16
    Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients

    Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients per Michael T. Tetzlaff, Kelly C. Nelson, Adi Diab, Gregg Staerkel, Priyadharsini Nagarajan, Carlos A. Torres‐Cabala, Beth Chasen, Jennifer A. Wargo, Víctor G. Prieto, Rodabe N. Amaria, Jonathan L. Curry

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Agonist Anti-GITR Antibody Enhances Vaccine-Induced CD8+ T-Cell Responses and Tumor Immunity

    Agonist Anti-GITR Antibody Enhances Vaccine-Induced CD8+ T-Cell Responses and Tumor Immunity per Adam D. Cohen, Adi Diab, Miguel‐Angel Perales, Jedd D. Wolchok, Gabrielle Rizzuto, Taha Merghoub, Deonka Huggins, Cailian Liu, Mary Jo Turk, Nicholas P. Restifo, Shimon Sakaguchi, Alan N. Houghton

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Infliximab for the treatment of patients with checkpoint inhibitor associated acute tubular interstitial nephritis

    Infliximab for the treatment of patients with checkpoint inhibitor associated acute tubular interstitial nephritis per Jamie S. Lin, Omar Mamlouk, Umut Selamet, Amanda Tchakarov, William F. Glass, Rahul A. Sheth, Rachel M. Layman, Ramona Dadu, Noha Abdel‐Wahab, Maen Abdelrahim, Adi Diab, Cassian Yee, Ala Abudayyeh

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation

    Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation per Adam D. Cohen, David Schaer, Cailian Liu, Yanyun Li, Daniel Hirschhorn-Cymmerman, Soo Chong Kim, Adi Diab, Gabrielle Rizzuto, Fei Duan, Miguel‐Angel Perales, Taha Merghoub, Alan N. Houghton, Jedd D. Wolchok

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature

    Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature per Noha Abdel‐Wahab, Houssein Safa, Ala Abudayyeh, Daniel H. Johnson, Van Anh Trinh, Chrystia M. Zobniw, Heather Lin, Michael K. Wong, Maen Abdelrahim, A. Osama Gaber, María E. Suärez-Almazor, Adi Diab

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:

Eines de cerca: